Abstract:Abstract Chimeric antigen receptor (CAR)-T cell therapy is an antigen-dependent cellular therapy that has gained considerable traction in the field of cancer immunotherapy. CAR-T cell therapy involves specifically engineering T cells to attack tumor cells by binding a tumor antigen and inducing T cell activation resulting in intracellular signaling and cytokine release. Currently, there are six FDA-approved CAR-T cell therapies, which all target the CD19 or BCMA antigens for hematologic B cell malignancies. In the recent years, a strong focus has been placed on CAR T cell therapy discovery for solid tumors, which may better recapitulate physiological conditions, thereby potentially improving the selection of CAR construct candidates. Immune cell trafficking and immunosuppressive factors within the tumor microenvironment increase the relative difficulty in developing a robust CAR-T cell therapy against solid tumors. Therefore, it is critical to develop novel methodologies for high-throughput phenotypic and functional assays using 3D tumor spheroid models to better assess CAR-T cell therapies against solid tumors. Recently, plate-based image cytometry has emerged as a method to investigate and characterize CAR T cell functions in a high-throughput manner. Image cytometry has demonstrated capabilities in analyzing transduction efficiency, cell proliferation, and cytotoxicity for CAR T cell therapy. With the development of 3D spheroid models, image cytometry may provide the necessary tools and applications for CAR T cell therapy discovery geared towards solid tumors. In this work, we discuss the use of CAR-T cells targeted towards PSMA, an antigen that is found on prostate cancer tumor cells, the second most common cause of cancer deaths among men worldwide. Herein, we demonstrate the use of high-throughput plate-based image cytometry to characterize PSMA CAR-T cell-mediated cytotoxic potency against 3D prostate tumor spheroids and simultaneously monitor location of the T cells in vitro. We were able to kinetically evaluate the efficacy and therapeutic value of PSMA CAR-T cells by analyzing the cytotoxicity against prostate tumor spheroids. Furthermore, the T cells are fluorescently labeled with a tracer dye to visually locate the cells on the tumor spheroids. The proposed image cytometry method can overcome limitations placed on traditional methodologies to effectively assess cell-mediated 3D tumor spheroid cytotoxicity and efficiently generate time- and dose-dependent results. Citation Format: Samir Patel, David Zurowski, Daniel Hui, Mignane Ka, Charles Hernandez, Andrea Love, Bo Lin, Andrea Moore, Leo Li-Ying Chan. High-throughput method to analyze the cytotoxicity of CAR T cells in a 3D tumor spheroid model using image cytometry. [abstract]. In: Proceedings of the American Association for Cancer Research Annual Meeting 2023; Part 1 (Regular and Invited Abstracts); 2023 Apr 14-19; Orlando, FL. Philadelphia (PA): AACR; Cancer Res 2023;83(7_Suppl):Abstract nr 4575.

Development of an antigen-based approach to noninvasively image CAR T cells in real time and as a predictive tool

Noninvasive longitudinal PET/CT imaging of CAR T cells using PSMA reporter gene

Current and potential roles of immuno-PET/-SPECT in CAR T-cell therapy

Engineering CAR-T cells for radiohapten capture in imaging and radioimmunotherapy applications

Imaging CAR T-cell kinetics in solid tumors: Translational implications

Ex Vivo Radiolabeling and In Vivo PET Imaging of T Cells Expressing Nuclear Reporter Genes

Noninvasive PET Imaging of T cells

Illuminating immunotherapy response via precision T cell-targeted PET imaging

Nuclear Imaging of CAR T Immunotherapy to Solid Tumors: in Terms of Biodistribution, Viability, and Cytotoxic Effect

Radionuclide-based molecular imaging allows CAR-T cellular visualization and therapeutic monitoring

Direct and Indirect Chimeric Antigen Receptor T-Cell Imaging with PET/MRI in a Tumor Xenograft Model

Molecular Imaging of Chimeric Antigen Receptor T Cells by ICOS-ImmunoPET

Imaging CAR-NK cells targeted to HER2 ovarian cancer with human sodium-iodide symporter-based positron emission tomography

Optimizing ex vivo CAR-T cell-mediated cytotoxicity assay through multimodality imaging

In vivo imaging of nanoparticle-labeled CAR T cells

Towards Precision CAR T-cell Immunotherapy: extended gate FET biosensor for personalized drug monitoring

Multi-parameter Optical Imaging of Immune Cell Activity in Chimeric Antigen Receptor T-cell and Checkpoint Blockade Therapies

Antigen-Dependent Inducible T-Cell Reporter System for PET Imaging of Breast Cancer and Glioblastoma

PET Imaging for Monitoring Cellular and Immunotherapy of Cancer

Abstract 4575: High-throughput method to analyze the cytotoxicity of CAR T cells in a 3D tumor spheroid model using image cytometry

PET Reporter Gene Imaging and Ganciclovir-Mediated Ablation of Chimeric Antigen Receptor T Cells in Solid Tumors